Oxford Asset Management’s Celularity CELU Stock Holding History

Oxford Asset Management’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$2M	Buy	+20,427	New	+$2.02M	0.28%	72

Other funds holding CELU

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Oxford Asset Management's CELU Position: Q1 2020 in Review

Oxford Asset Management opened a new position in Celularity (CELU) in Q1 2020: 20,427 shares worth $2M. The stake represents 0.28% of the portfolio and ranks #72 among its holdings.

35 funds tracked by Wall St. Rank hold CELU as of Q1 2020.

Oxford Asset Management held 20,427 shares of Celularity worth $2M as of Q1 2020.
Celularity was a new Oxford Asset Management position in Q1 2020.
Celularity made up 0.28% of Oxford Asset Management's portfolio in Q1 2020, its #72 holding.
35 funds tracked by Wall St. Rank held Celularity as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.